Use of a computerized database to study the effectiveness of an attenuated varicella vaccine

Pediatric Infectious Disease Journal

Volumn 23, Issue 3, 2004, Pages 221-226

  Passwell, Justen H ^a,c   Hemo, Beatrice ^c   Levi, Yonit ^a   Ramon, Reut ^a   Friedman, Nurit ^c   Lerner Geva, Liat ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Database; Immunization; Incidence; Primary care; Varicella

Indexed keywords

CHICKENPOX VACCINE; LIVE VACCINE;

ARTICLE; CHICKENPOX; CHILD; COMPUTER ANALYSIS; DATA BASE; DRUG EFFICACY; DRUG USE; FOLLOW UP; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PRIORITY JOURNAL; SOCIAL STATUS; VACCINATION;

CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; FEMALE; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; INCIDENCE; INFANT; ISRAEL; MALE; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; VACCINES, ATTENUATED;

EID: 1542723748     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000114906.78716.64     Document Type: Article

References (19)

1. Gershon AA. Live-attenuated varicella vaccine. Infect Dis Clin North Am 2001;15:65-81.
2. Seward JF, Watson BM, Peterson CL, et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA 2002;287:606-11.
3. Weibel RE, Neff BJ, Kuter BJ, et al. Live attenuated varicella virus vaccine: efficacy trial in healthy children, N Engl J Med 1984;310:1409-15.
4. Vazquez M, LaRussa PS, Gershon AA, Steinberg SP, Freudigman K, Shapiro ED. The effectiveness of the varicella vaccine in clinical practice, N Engl J Med 2001;344:955-9.
5. Johnson CE, Stancin T, Fattlar D, Rome LP, Kumar ML. A long-term prospective study of varicella vaccine in healthy children. Pediatrics 1997;100:761-6.
6. Watson B, Seward J, Yang A, et al. Postexposure effectiveness of varicella vaccine. Pediatrics 2000;105:84-8.
7. Vessey SJ, Chan CY, Kuter BJ, et al. Childhood vaccination against varicella: persistence of antibody, duration of protection and vaccine efficacy. J Pediatr 2001;139:297-304.
8. Meurice F, De Bouver JL, Vandervoorde D, Woods S, Bogaerts H. Immunogenicity and safety of a live attenuated varicella vaccine (Oka/S B Bio) in healthy children. J Infect Dis 1996;174:S324-9.
9. Singhvi R, Markusen JF, Ky B, Horvath BJ, Aunins JG. Assessment of virus infection in cultured cells using metabolic monitoring. Cytotechnology 1996;22:79-85.
10. Varis T, Vesikari T. Efficacy of high-titer live attenuated varicella vaccine in healthy young children. J Infect Dis 1996;174:S330-4.
11. TM in healthy children. Vaccine 2002;20:2942-9.
12. Wasmuth EH, Miller WJ. Sensitive enzyme-linked immunosorbent assay for antibody to varicella-zoster virus using purified VZV glycoprotein antigen. J Med Virol 1990;32:189-93.
13. Williams V, Gershon A, Brunell P. Serologic response to varicella-zoster membrane antigen measured by indirect immunofluorescence. J Infect Dis 1974;130:669-72.
14. Arvin A, Gershon A. Live attenuated varicella vaccine. Annu Rev Microbiol 1996;50:59-100.
15. Somekh E, Bujanover Y, Tal G, Tanay A, Lehman D. An intradermal skin test for determination of immunity to varicella. Arch Dis Child 2001;85:484-6.
16. Dworkin MS, Jennings CE, Roth-Thomas J, Lang JE, Stukenberg C, Lumpkin JR. An outbreak of varicella among children attending preschool and elementary school in Illinois. Clin Infect Dis 2002;35:102-4.
17. Galil KI, Fair E, Mountcastle N, Britz P, Seward J. Younger age at vaccination may increase risk of varicella vaccine failure. J Infect Dis 2002;186:102-5.
18. Galil K, Lee B, Strine T, et al. Outbreak of varicella at a day-care center despite vaccination. N Engl J Med 2002;347:1909-15.
19. Li S, Chan ISF, Matthews H, et al. Inverse relationship between six week postvaccination varicella antibody response to vaccine and likelihood of long term breakthrough infection. Pediatr Infect Dis J 2002;21:337-42.